|
Market Closed -
NSE India S.E.
19:05:08 26/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2,438.30 INR | +1.60% |
|
+8.54% | +19.81% |
| Market Cap | 677B 7.1B 6.09B 5.7B 5.21B 9.83B 9.93B 67.28B 26.19B 342B 26.68B 26.09B 1,132B | P/E 2027 * |
29.2x | P/E 2028 * | 24.3x |
|---|---|---|---|---|---|
| Enterprise Value | 641B 6.72B 5.76B 5.4B 4.93B 9.3B 9.4B 63.66B 24.78B 323B 25.24B 24.69B 1,071B | EV / Sales 2027 * |
3.82x | EV / Sales 2028 * | 3.36x |
| Free-Float |
51.04% | Yield 2027 * |
0.16% | Yield 2028 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.60% | ||
| 1 week | +8.54% | ||
| Current month | +9.15% | ||
| 1 month | +11.03% | ||
| 3 months | +3.70% | ||
| 6 months | +14.78% | ||
| Current year | +19.81% |
| 1 week | 2,252.1 |  | 2,457.5 |
| 1 month | 2,162 | | 2,457.5 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 14/08/2020 | |
Patricia Andrews
BRD | Director/Board Member | 68 | 14/08/2025 |
| Director/Board Member | 71 | 14/02/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.60% | +8.54% | +25.00% | +217.84% | 7.1B | |
| -1.17% | -0.03% | +18.70% | +70.05% | 48.37B | |
| +1.12% | +1.41% | +54.88% | +122.68% | 39.88B | |
| -1.36% | -1.36% | -11.21% | +14.14% | 12.05B | |
| +2.27% | +4.12% | +16.41% | +81.30% | 11.77B | |
| +0.19% | 0.00% | +30.98% | +150.00% | 9.19B | |
| -0.67% | +3.03% | +24.25% | +45.03% | 7.87B | |
| +1.30% | +1.26% | +54.43% | -10.73% | 7.25B | |
| +0.95% | -8.22% | -39.88% | +16.67% | 5.26B | |
| -0.09% | -3.95% | +37.71% | +105.96% | 4.66B | |
| Average | +0.41% | +0.21% | +21.13% | +81.29% | 15.34B | |
| Weighted average by Cap. | +0.13% | +1.01% | +27.15% | +85.99% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.76B 1.51B 1.41B 1.29B 2.44B 2.46B 16.68B 6.49B 84.72B 6.61B 6.47B 281B | 187B 1.96B 1.68B 1.58B 1.44B 2.72B 2.74B 18.59B 7.24B 94.41B 7.37B 7.21B 313B |
| Net income | 23.11B 242M 208M 195M 178M 336M 339M 2.3B 894M 11.66B 910M 890M 38.61B | 27.71B 291M 249M 233M 213M 402M 406M 2.75B 1.07B 13.98B 1.09B 1.07B 46.29B |
| Net Debt | -36.49B -383M -328M -307M -281M -530M -535M -3.63B -1.41B -18.41B -1.44B -1.41B -60.97B | -48B -504M -431M -404M -369M -697M -704M -4.77B -1.86B -24.22B -1.89B -1.85B -80.2B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/08/26 | ₹2,438.30 | +1.60% | 479,931 |
| 25/08/26 | ₹2,400.00 | +0.39% | 653,245 |
| 24/08/26 | ₹2,390.70 | +3.14% | 710,023 |
| 21/08/26 | ₹2,317.90 | -0.64% | 237,421 |
| 20/08/26 | ₹2,332.90 | +3.85% | 552,157 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
